[Endometrial cancer: Predictive models and clinical impact]

Area of Science:

• Gynecologic Oncology
• Biomathematics
• Genomics

Background:

• Endometrial cancer (CE) is a leading cause of cancer incidence and mortality in women in France.
• Current treatment decisions rely on prognostic factors and classification systems that inadequately capture CE's heterogeneity.
• Existing predictive models for CE recurrence and metastasis often lack clinical utility.

Purpose of the Study:

• To explore the potential of mathematical modeling in predicting endometrial cancer (CE) outcomes.
• To highlight the need for improved predictive tools for personalized CE treatment strategies.
• To discuss the future integration of biomathematical tools and genomics in CE management.

Main Methods:

• Review of existing literature on mathematical modeling and prognostic factors in endometrial cancer (CE).
• Analysis of the limitations of current classification systems for predicting CE recurrence and metastasis.
• Discussion of the potential impact of high-throughput genomics on CE characterization.

Main Results:

• Mathematical modeling offers a promising approach to predict endometrial cancer (CE) recurrence and lymph node metastasis.
• A significant gap exists between published predictive models and those with demonstrated clinical utility.
• Genomic advancements are expected to provide deeper insights into CE heterogeneity.

Conclusions:

• Biomathematical models are crucial for advancing targeted therapies and personalized medicine in endometrial cancer (CE).
• Further development and validation are needed to enhance the clinical relevance of predictive models.
• Integrating mathematical modeling with genomic data will likely revolutionize endometrial cancer (CE) management.